Asahi Kasei Therapeutics Corp - Company Profile

Powered by

All the sales intelligence you need on Asahi Kasei Therapeutics Corp in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Asahi Kasei Therapeutics Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Asahi Kasei Therapeutics Corp.

Back to companies

Asahi Kasei Therapeutics Corp: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Asahi Kasei Therapeutics Corp patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
DK3609868T3 Application Tetrahydroquinolinderivater som p2x7-receptorantagonister A61K31/438; A61K31/47; A61K31/4709; A61K31/4747; A61K31/5375; A61K31/5386; A61P13/12; A61P19/00; A61P25/00; A61P29/00; A61P35/00; A61P37/00; A61P43/00; A61P9/06; C07D215/06; C07D215/20; C07D215/48; C07D221/04; C07D401/06; C07D401/12; C07D405/12; C07D417/12; C07D417/14; C07D471/10; C07D491/08; C07D491/107; C07D498/10; C07F7/1804 November 27, 2023
FI3609868T3 Grant Tetrahydroquinoline derivatives as p2x7 receptor antagonists C07D417/12; C07D491/107; A61P25/00; A61P37/00; C07F7/1804; C07D401/06; C07D417/14; C07D471/10; A61K31/4709; A61K31/5386; C07D221/04; A61P35/00; C07D401/12; C07D215/06; C07D405/12; C07D498/10; A61P43/00; A61P29/00; A61K31/47; A61P19/00; C07D215/48; A61K31/4747; A61K31/5375; C07D215/20; A61K31/438; C07D491/08; A61P13/12; A61P9/06 November 22, 2023
JP2023166000A Application フェロシアン化物の酸化還元電位を大きくするプロテアーゼの安定化剤を含む糖化タンパク質測定試薬、糖化タンパク質の測定方法、糖化タンパク質測定試薬の保存方法、及び糖化タンパク質測定試薬の安定化方法 C12Q1/26; C12Q1/37; C12Q2326/96; G01N2333/90638; G01N2440/38; G01N33/68 November 17, 2023
AU2019347406B9 Grant Medication for alleviating symptoms of peripheral neuropathy caused by anticancer drug and/or suppressing onset of peripheral neuropathy A61K31/555; A61K38/366; A61K47/183; A61K9/0019; A61K9/19; A61P25/02; A61P35/00; A61P43/00; C07K14/7056; C07K14/7455 November 16, 2023
US20230357271A1 Application Macrocyclic compound C07D498/18 November 09, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer